These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3265277)

  • 21. [The difference in fatty acid transfer in very low- and low-density lipoproteins and the biological bases of correction of familial hyperlipoproteinemias].
    Titov VN
    Klin Lab Diagn; 2005 Jul; (7):3-10. PubMed ID: 16127988
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modified lipoproteins and atherogenesis].
    Fruchart JC; Sauzières J; Plancke MO; Luc G; Clavey V
    Presse Med; 1989 Apr; 18(14):701-2. PubMed ID: 2524746
    [No Abstract]   [Full Text] [Related]  

  • 23. [Surgical treatment of hyperlipoproteinemia].
    Kurguzov OP; Sergeev VV; Tatevosian AS
    Khirurgiia (Mosk); 1991 Jan; (1):125-30. PubMed ID: 2041309
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxidized low density lipoprotein--an extreme example of lipoprotein heterogeneity.
    Steinberg D
    Isr J Med Sci; 1996 Jun; 32(6):469-72. PubMed ID: 8682653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidation of LDL by nitric oxide and its modification by superoxides in macrophage and cell-free systems.
    Wang JM; Chow SN; Lin JK
    FEBS Lett; 1994 Apr; 342(2):171-5. PubMed ID: 8143872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein: binding to lipids and lipoproteins.
    Pepys MB; Rowe IF; Baltz ML
    Int Rev Exp Pathol; 1985; 27():83-111. PubMed ID: 3915746
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of atherogenic low density lipoproteins (LDL) in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Arai H; Nagano Y
    Ann N Y Acad Sci; 1990; 598():188-93. PubMed ID: 2248438
    [No Abstract]   [Full Text] [Related]  

  • 28. [Insulin-dependent diabetes and lipoprotein metabolism].
    Berthezène F; Perrot L; Valentin C; Sautot G
    Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
    [No Abstract]   [Full Text] [Related]  

  • 29. Is lipid oxidation essential for atherogenesis?
    Mitchinson MJ
    J Clin Pathol; 1997 Apr; 50(4):268. PubMed ID: 9215137
    [No Abstract]   [Full Text] [Related]  

  • 30. Transport of lipoproteins into the artery.
    Ghosh S
    Artery; 1979 Apr; 5(4):354-61. PubMed ID: 233551
    [No Abstract]   [Full Text] [Related]  

  • 31. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probucol protects lipoprotein (a) against oxidative modification.
    Naruszewicz M; Selinger E; Dufour R; Davignon J
    Metabolism; 1992 Nov; 41(11):1225-8. PubMed ID: 1435295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of probucol on early experimental atherogenesis in hypercholesterolemic rats.
    Shankar R; Sallis JD; Stanton H; Thomson R
    Atherosclerosis; 1989 Aug; 78(2-3):91-7. PubMed ID: 2783208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidised low density lipoproteins and atherogenesis.
    Leake DS
    Br Heart J; 1993 Jun; 69(6):476-8. PubMed ID: 8343310
    [No Abstract]   [Full Text] [Related]  

  • 35. An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis.
    Beisiegel U; St Clair RW
    Curr Opin Lipidol; 1996 Oct; 7(5):265-8. PubMed ID: 8937514
    [No Abstract]   [Full Text] [Related]  

  • 36. A critical look at the evidence for the oxidation of LDL in atherogenesis.
    Steinberg D
    Atherosclerosis; 1997 Jun; 131 Suppl():S5-7. PubMed ID: 9253467
    [No Abstract]   [Full Text] [Related]  

  • 37. The oxidative modification hypothesis of atherogenesis: an overview.
    Chisolm GM; Steinberg D
    Free Radic Biol Med; 2000 Jun; 28(12):1815-26. PubMed ID: 10946223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoimmune theory of atherogenesis and the concept of modified lipoproteins].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1990; (11):30-6. PubMed ID: 2284842
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of hyperlipoproteinemia.
    Grundy SM
    J Lipid Res; 1984 Dec; 25(13):1611-8. PubMed ID: 6397565
    [No Abstract]   [Full Text] [Related]  

  • 40. Iron and LDL-oxidation in atherogenesis.
    Yuan XM; Brunk UT
    APMIS; 1998 Sep; 106(9):825-42. PubMed ID: 9808409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.